Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FHL-101 by Forest Hills Partners Hong Kong for Unspecified Neurologic Disorders: Likelihood of Approval
FHL-101 is under clinical development by Forest Hills Partners Hong Kong and currently in Phase I for Unspecified Neurologic Disorders....